Cycurion, Inc. Form 8-K Summary
Business Context and Reporting Period
Cycurion, Inc. (NASDAQ: CYCU) filed a Current Report on Form 8-K dated April 7, 2025. The filing discloses the entry into a material definitive agreement to secure an equity line of credit facility.
Key Financial Metrics and Transaction Terms
- Maximum Commitment Amount: $60,000,000 in shares of common stock available for purchase by the investor.
- Commitment Fee: $1,800,000 payable in cash or via issuance of a pre-funded warrant.
- Pre-Funded Warrant Details: If issued, the warrant covers up to 4,500,000 shares with an exercise price of $0.0001 per share.
- Purchase Price Mechanism: Shares sold under the agreement will be priced at 90% of the lowest trade of the common stock during the defined valuation period.
- Ownership Cap: The investor is restricted from beneficially owning more than 4.99% of the company's common stock immediately after exercise, unless increased to 9.99% with 61 days' prior notice.
Material Changes and Agreements
On April 7, 2025, the Company entered into an Equity Purchase Agreement with Yield Point NY LLC. This agreement grants the Company the right, but not the obligation, to direct the Investor to purchase shares of common stock up to the $60 million maximum commitment. The agreement also includes a Registration Rights Agreement requiring the filing of an Initial Registration Statement on Form S-1 by May 7, 2025, covering the resale of commitment stock and put stock.
Outlook, Obligations, and Risks
- Registration Timeline: The Company must file the Initial Registration Statement by May 7, 2025, and use best efforts to have it declared effective by July 7, 2025.
- Term of Agreement: The commitment period ends on the earlier of: (i) the date the Maximum Commitment Amount is fully utilized; (ii) 12 months from the effectiveness of the registration statement; (iii) written termination by the Company (subject to conditions); or (iv) written termination by the Investor.
- Dilution Risk: Future issuances under this agreement will result in dilution to existing shareholders, with shares sold at a discount (90%) to the market price.
- Liquidity: The filing does not provide specific current cash balance or liquidity metrics, but the agreement is designed to provide access to capital.
Key Facts for Investor Verification
- Verify the Company's decision to pay the $1.8 million commitment fee in cash versus issuing the pre-funded warrant.
- Monitor the filing and effectiveness date of the Form S-1 registration statement (deadline: July 7, 2025).
- Track the Company's utilization of the $60 million equity line and the associated dilution impact.
- Review the full text of the Equity Purchase Agreement (Exhibit 10.23) for specific definitions of the "Valuation Period" and "Maximum Put Amount."